- Latest news▼
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
-
08:38, April 17 Why do kids usually recover from COVID-19 more easily than adults?
-
14:37, April 16 Daily Mail: intermittent fasting is not suitable for children and women before their periods
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
-
18:42, April 13 WHO: Nigeria pioneers revolutionary meningitis vaccine
-
16:43, April 13 One-third of women experience menstruation-related migraines, most often during premenopause - study
All materials
Allergen-specific immunotherapy may reduce risk of asthma progression
Allergen-specific immunotherapy (AIT) can reduce the risk of asthma progression, especially in young patients, Medical Press reported.
Scientists from the Technical University of Dresden, Jochen Schmitt, used German health insurance data (2005–2014) to study the effects of AIT on asthma progression.
Scientists examined 39 167 people (aged ≥14 years) with asthma. Just over 10 percent of these people (10.5 percent) received AIT. When exposed to AIT, there was a significant reduction in the risk of asthma progression. Allergen-specific immunotherapy had a greater effect on younger age groups. This finding confirms current recommendations for initiating causal therapy with AIT in the early stages of the disease.
Our study confirms the suggestion that treatment with AIT can prevent progression from mild to more severe asthma, the author said.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Pediatrics: Hypoglossal nerve stimulation implant helps with sleep apnea 1358
- Health minister: Simulation educational center will be created, assisted reproductive technology capacity will increase in Armenia 1314
- WHO: Nigeria pioneers revolutionary meningitis vaccine 1166
- One-third of women experience menstruation-related migraines, most often during premenopause - study 1134
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 926
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 904
- Food and Environmental Virology: tea contributes to effective coronavirus control 904
- Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk 874
- 305 cases of measles recorded in Armenia so far in 2024 868
- Diabetes Care: evening physical activity is good for the heart 858
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 682
- First Armenian-German Conference entitled “Heart Failure Spring School” 474
- Why do kids usually recover from COVID-19 more easily than adults? 336
- Obesity: exercising before breakfast helps you lose weight faster 321
- The Conversation: childhood trauma can cause pathological hoarding 316
- Find us on Facebook
- Poll